Schonfeld Group Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$746K Buy
24,347
+10,540
+76% +$332K 0.47% 59
2015
Q3
$411K Buy
+13,807
New +$443K 0.21% 90
2014
Q2
Sell
-159,966
Closed -$4.88M 261
2014
Q1
$4.88M Buy
159,966
+43,543
+37% +$1.3M 1.22% 9
2013
Q4
$3.38M Buy
+116,423
New +$3.39M 1.28% 13

Other funds holding PFE

Schonfeld Group Holdings's PFE Position: Q4 2015 in Review

Schonfeld Group Holdings increased its Pfizer (PFE) stake by 76% in Q4 2015, buying an estimated $332K and bringing the position to 24,347 shares worth $746K. The position accounts for 0.47% of the portfolio, ranked #59.

Schonfeld Group Holdings first reported a position in PFE in Q4 2013 and has held it in 4 quarters since. The position peaked at $4.88M in Q1 2014. 1,969 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Schonfeld Group Holdings held 24,347 shares of Pfizer worth $746K as of Q4 2015.
  • Schonfeld Group Holdings bought 10,540 Pfizer shares in Q4 2015, an estimated $332K.
  • Pfizer made up 0.47% of Schonfeld Group Holdings's portfolio in Q4 2015, its #59 holding.
  • Schonfeld Group Holdings first reported a position in Pfizer in Q4 2013 and has held it in 4 quarters since.
  • Schonfeld Group Holdings's Pfizer position peaked at $4.88M in Q1 2014.
  • 1,969 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.